Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Acute Kidney Injury
Interventions
DEVICE

Selective Cytopheretic Device

"The Selective Cytopheretic Device (SCD) is comprised of tubing, connectors, and a synthetic hollow fiber membrane cartridge. The device is connected in series to a commercially available CKRT hemofilter. Blood from the CKRT circuit is diverted after the CKRT hemofilter through to the extracapillary space (ECS) of the SCD cartridge. Blood circulates through the SCD ECS and then it is returned to the patient via the venous return line of the CKRT circuit. Regional citrate anticoagulation is used for the entire CKRT and SCD blood circuit.~The SCD cartridge incorporates a synthetic hollow fiber membrane with the ability to bind activated leukocytes to its extracapillary surface; and when used in a CKRT extracorporeal circuit in the presence of regional citrate anticoagulation, the SCD modulates inflammation."

OTHER

Standard of Care

Standard of care CKRT for the subject's condition, as appropriate

Trial Locations (29)

14627

WITHDRAWN

Unversity of Rochester, Rochester

19015

NOT_YET_RECRUITING

St Luke's University Hospital, Bethlehem

19047

RECRUITING

Saint Mary Medical Center, Langhorne

19152

NOT_YET_RECRUITING

Nazareth Hospital, Philadelphia

23219

NOT_YET_RECRUITING

Virginia Commonwealth University, Richmond

23507

RECRUITING

Sentara Health, Norfolk

30909

WITHDRAWN

JMS Burn Center, Augusta

32806

NOT_YET_RECRUITING

Orlando Regional Medical Center, Orlando

35233

NOT_YET_RECRUITING

University of Alabama Birmingham Hospital, Birmingham

40536

WITHDRAWN

University of Kentucky HealthCare, Lexington

44195

RECRUITING

Cleveland Clinic, Cleveland

45219

RECRUITING

University of Cincinnati, Cincinnati

48109

RECRUITING

University of Michigan, Ann Arbor

48202

RECRUITING

Henry Ford Medical Center, Detroit

52242

RECRUITING

University of Iowa Hospital, Iowa City

55902

RECRUITING

Mayo Clinic, Rochester

71103

RECRUITING

Ochsner LSU Health Academic Medical Center, Shreveport

72205

WITHDRAWN

Central Arkansas Veterans Healthcare, Little Rock

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

78212

RECRUITING

Methodist Hospital Metropolitan, San Antonio

78229

RECRUITING

Methodist Hospital, San Antonio

RECRUITING

University of Texas Health San Antonio, San Antonio

78234

RECRUITING

Brooke Army Medical Center, Fort Sam Houston

RECRUITING

United States Army Institute of Surgical Research, JBSA Fort Sam Houston

80045

WITHDRAWN

University of Colorado Hospital Anschutz Medical Campus, Aurora

89154

NOT_YET_RECRUITING

UNLV Health, Las Vegas

90095

NOT_YET_RECRUITING

Ronald Reagan UCLA Medical Center, Los Angeles

94304

RECRUITING

Stanford University, Palo Alto

97330

RECRUITING

Samaritan Health, Corvallis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

SeaStar Medical

INDUSTRY

NCT05758077 - Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury | Biotech Hunter | Biotech Hunter